Home » Genetronics Acquires Inovio AS
Genetronics Acquires Inovio AS
Genetronics Biomedical, a late stage developer of oncology and other therapies using electroporation to deliver drugs and nucleic acids, has announced the acquisition of Oslo-based Inovio AS, a leader in patented gene delivery technology for the most efficient, nonviral method for gene transfer to skeletal muscles. Inovio's use of electroporation for gene therapy and DNA vaccines is a complement to Genetronics' existing electroporation therapy program.
BioSpace (http://www.biospace.com/news_story.cfm?StoryID=18810320&full=1)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May